ClinicalTrials.Veeva

Menu

Ocular Manifestations in Rheumatic Diseases

L

Lawson Health Research Institute

Status

Completed

Conditions

Chorioretinitis
Retinal Artery Occlusion
Orbital Diseases
Macular Edema
Amaurosis Fugax
Eye Hemorrhage
Optic Neuritis
Choroid Hemorrhage
Blindness
Papilledema
Conjunctivitis
Uveitis
Retinal Vein Occlusion
Retinitis
Iridocyclitis
Scleritis
Xerophthalmia
Keratoconjunctivitis Sicca

Treatments

Other: No intervention used

Study type

Observational

Funder types

Other

Identifiers

NCT03753893
MTJP001

Details and patient eligibility

About

This is a search strategy for determining the prevalence of ocular complications in inflammatory rheumatic diseases for the purposes of a meta analysis.

Full description

For the purposes of determining the prevalence of ocular complications in inflammatory rheumatic diseases, the following search terms were used: conjunctivitis, keratoconjunctivitis sicca, xerophthalmia, uveitis, eye hemorrhage, optic neuritis, papilledema, orbital disease, retinal artery/vein occlusion, macular edema, retinitis, chorioretinitis, scleritis, iridocyclitis, choroid hemorrhage, blindness and amaurosis fugax.

These terms were searched in the context of a corresponding inflammatory disease on Medline, Cochrane and Web of Science from their inception (1966, 1991 and 1990 respectively) until the point of study completion.

Studies were included if they provided numerical data of the prevalence or incidence of ocular manifestations in an inflammatory rheumatic disease. Studies were excluded if they were review articles, case reports where all patients experienced the same ocular comorbidity, if different comorbidities were not grouped independently, and if the study reported on fewer than 20 patients. When the same study cohort was used in more than one analysis, the most recent or largest sample-size study was included. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist was used to assess the quality of cohort, case-control, and cross-sectional studies.

Enrollment

5,000 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Studies were included if they provided numerical data of the prevalence or incidence of ocular manifestations in inflammatory rheumatic disease

Exclusion criteria

  • review articles,
  • case reports where all patients experienced the same ocular comorbidity
  • if different comorbidities were not grouped independently
  • if the study reported on fewer than 20 patients

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems